SPONSOR
Ludwig-Maximilians - University of Munich
Total Trials
2
Recruiting
2
Phases
Phase 2
NCT06806059
Recruiting
Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity
Urothelial Carcinoma Bladder
NCT04224636 Phase 2
Recruiting
Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab
Hepatocellular Carcinoma Non-resectable